mid-Jan 2014 in ARIA# Stock
E*r
1 楼
ARIAD will resume selling the therapy from mid-Jan 2014 under a modified
prescribing and risk management plan approved by the FDA.
http://finance.yahoo.com/news/ariads-iclusig-204503488.html
prescribing and risk management plan approved by the FDA.
http://finance.yahoo.com/news/ariads-iclusig-204503488.html